Evidence map›Paper›PMID 32349302›Full record

ArticleToxins2020

Revisiting the Neuroblastoma Cell-Based Assay (CBA-N2a) for the Improved Detection of Marine Toxins Active on Voltage Gated Sodium Channels (VGSCs).

Jérôme Viallon, Mireille Chinain, Hélène Taiana Darius

Open access · goldAbstract readValidation Study
In one paragraph

Article in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Anti-Inflammatory Effect of Extract fromJournal of microbiology and biotechnology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jérôme ViallonInstitut Louis Malardé (ILM), Laboratory of Marine Biotoxins-UMR 241-EIO, 98713 Papeete-Tahiti, French Polynesia.
Mireille ChinainInstitut Louis Malardé (ILM), Laboratory of Marine Biotoxins-UMR 241-EIO, 98713 Papeete-Tahiti, French Polynesia.
Hélène Taiana DariusInstitut Louis Malardé (ILM), Laboratory of Marine Biotoxins-UMR 241-EIO, 98713 Papeete-Tahiti, French Polynesia.ORCID 0000-0002-1184-7034
Institut Louis Malardé · PF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuroblastoma cell-based assay (CBA-N2a) is widely used for the detection of marine biotoxins in seafood products, yet a consensus protocol is still lacking. In this study, six key parameters of CBA-N2a were revisited: cell seeding densities, cell layer viability after 26 h growth, MTT incubation time, Ouabain and Veratridine treatment and solvent and matrix effects. A step-by-step protocol was defined identifying five viability controls for the validation of CBA-N2a results. Specific detection of two voltage gated sodium channel activators, pacific ciguatoxin (P-CTX3C) and brevetoxin (PbTx3) and two inhibitors, saxitoxin (STX) and decarbamoylsaxitoxin (dc-STX) was achieved, with EC

Indexed as

Biological AssayAnimalsCell Line, TumorCell ProliferationCell SurvivalCiguatoxinsDose-Response Relationship, DrugFishesLimit of DetectionMarine ToxinsMiceNeuroblastomaNeuronsOuabainOxocinsPolyether ToxinsbrevetoxinCiguatoxinsMarine ToxinsOuabainOxocinsPolyether ToxinsSaxitoxinVeratridineVoltage-Gated Sodium Channel AgonistsVoltage-Gated Sodium Channelsabsorbance databiological samplebrevetoxinsCBA-N2aciguatoxinsmatrix effectssaxitoxinsseafood safetystandardization

Identifiers

PMID32349302
PMCPMC7290318
OpenAlexW3021429608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.